NCT06864988Phase 3Active not recruiting

4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

Study sponsor: 4D Molecular Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-06Estimated
Enrollment · participants480Estimated
Source updated2026-10-26Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

· 1 field changed

Planned enrollment increased by 80 participants

Before: 400 participants (planned). After: 480 participants (planned).

Check registry source